|
1
|
Kim V and Aaron SD: What is a COPD
exacerbation? Current definitions, pitfalls, challenges and
opportunities for improvement. Eur Respir J.
52(1801261)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu X, Jiao X, Gong X, Nie Q, Li Y, Zhen
G, Cheng M, He J, Yuan Y and Yang Y: Prevalence, risk factor and
clinical characteristics of venous thrombus embolism in patients
with acute exacerbation of COPD: A prospective multicenter study.
Int J Chron Obstruct Pulmon Dis. 18:907–917. 2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Song YJ, Zhou ZH, Liu YK, Rao SM and Huang
YJ: Prothrombotic state in senile patients with acute exacerbations
of chronic obstructive pulmonary disease combined with respiratory
failure. Exp Ther Med. 5:1184–1188. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gegin S, Karakaya T, Aksu EA, Özdemir B,
Özdemir L and Pazarlı AC: The distribution of hereditary risk
factors in patients with pulmonary thromboembolism without
identifiable acquired risk factors. Duzce Med J. 27:69–74.
2025.
|
|
5
|
Yan C, Wu H, Fang X, He J and Zhu F:
Platelet, a key regulator of innate and adaptive immunity. Front
Med (Lausanne). 10(1074878)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bakogiannis C, Sachse M, Stamatelopoulos K
and Stellos K: Platelet-derived chemokines in inflammation and
atherosclerosis. Cytokine. 122(154157)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rawish E, Nording H, Münte T and Langer
HF: Platelets as mediators of neuroinflammation and thrombosis.
Front Immunol. 11(548631)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
van der Vorm LN, Li L, Huskens D, Hulstein
JJJ, Roest M, de Groot PG, Ten Cate H, de Laat B, Remijn JA and
Simons SO: Acute exacerbations of COPD are associated with a
prothrombotic state through platelet-monocyte complexes,
endothelial activation and increased thrombin generation. Respir
Med. 171(106094)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Harrison MT, Short P, Williamson PA,
Singanayagam A, Chalmers JD and Schembri S: Thrombocytosis is
associated with increased short and long term mortality after
exacerbation of chronic obstructive pulmonary disease: A role for
antiplatelet therapy? Thorax. 69:609–615. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nieri D, Morani C, De Francesco M, Gaeta
R, Niceforo M, De Santis M, Giusti I, Dolo V, Daniele M, Papi A, et
al: Enhanced prothrombotic and proinflammatory activity of
circulating extracellular vesicles in acute exacerbations of
chronic obstructive pulmonary disease. Respir Med.
223(107563)2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jiménez-Zarazúa O, González-Carrillo PL,
Vélez-Ramírez LN, Vélez-Ramírez LN, Alcocer-León M, Salceda-Muñoz
PAT, Palomares-Anda P, Nava-Quirino OA, Escalante-Martínez N,
Sánchez-Guzmán S and Mondragón JD: Survival in septic shock
associated with thrombocytopenia. Heart Lung. 50:268–276.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xiang M, Wu X, Jing H, Liu L, Wang C, Wang
Y, Novakovic VA and Shi J: The impact of platelets on pulmonary
microcirculation throughout COVID-19 and its persistent activating
factors. Front Immunol. 13(955654)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Barbar S, Noventa F, Rossetto V, Ferrari
A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A and
Prandoni P: A risk assessment model for the identification of
hospitalized medical patients at risk for venous thromboembolism:
The Padua Prediction Score. J Thromb Haemost. 8:2450–2457.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fawzy A, Anderson JA, Cowans NJ, Crim C,
Wise R, Yates JC and Hansel NN: Association of platelet count with
all-cause mortality and risk of cardiovascular and respiratory
morbidity in stable COPD. Respir Res. 20(86)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Semple JW, Italiano JE Jr and Freedman J:
Platelets and the immune continuum. Nat Rev Immunol. 11:264–274.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Nicolai L and Massberg S: Platelets as key
players in inflammation and infection. Curr Opin Hematol. 27:34–40.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yamada S and Asakura H: How we interpret
thrombosis with thrombocytopenia syndrome? Int J Mol Sci.
25(4956)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rahimi-Rad MH, Soltani S, Rabieepour M and
Rahimirad S: Thrombocytopenia as a marker of outcome in patients
with acute exacerbation of chronic obstructive pulmonary disease.
Pneumonol Alergol Pol. 83:348–351. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Thomas MR and Storey RF: The role of
platelets in inflammation. Thromb Haemost. 114:449–458.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Iba T, Umemura Y, Wada H and Levy JH:
Roles of coagulation abnormalities and microthrombosis in sepsis:
Pathophysiology, diagnosis, and treatment. Arch Med Res.
52:788–797. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mandel J, Casari M, Stepanyan M, Martyanov
A and Deppermann C: Beyond hemostasis: Platelet Innate immune
interactions and thromboinflammation. Int J Mol Sci.
23(3868)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wen H and Chen Y: The predictive value of
platelet to lymphocyte ratio and D-dimer to fibrinogen ratio
combined with WELLS score on lower extremity deep vein thrombosis
in young patients with cerebral hemorrhage. Neurol Sci.
42:3715–3721. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zaid Y and Merhi Y: Implication of
platelets in immuno-thrombosis and thrombo-inflammation. Front
Cardiovasc Med. 9(863846)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gasparyan AY, Ayvazyan L, Mukanova U,
Yessirkepov M and Kitas GD: The platelet-to-lymphocyte ratio as an
inflammatory marker in rheumatic diseases. Ann Lab Med. 39:345–357.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xue J, Ma D, Jiang J and Liu Y: Diagnostic
and prognostic value of immune/inflammation biomarkers for venous
thromboembolism: Is it reliable for clinical practice? J Inflamm
Res. 14:5059–5077. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yao C, Zhang Z, Yao Y, Xu X, Jiang Q and
Shi D: Predictive value of neutrophil to lymphocyte ratio and
platelet to lymphocyte ratio for acute deep vein thrombosis after
total joint arthroplasty: A retrospective study. J Orthop Surg Res.
13(40)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim NY, Chun DH, Kim SY, Kim NK, Baik SH,
Hong JH, Kim KS and Shin CS: Prognostic value of systemic
inflammatory indices, NLR, PLR, and MPV, for predicting 1-year
survival of patients undergoing cytoreductive surgery with HIPEC. J
Clin Med. 8(589)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yüksel M, Yıldız A, Oylumlu M, Akyüz A,
Aydın M, Kaya H, Acet H, Polat N, Bilik MZ and Alan S: The
association between platelet/lymphocyte ratio and coronary artery
disease severity. Anatol J Cardiol. 15:640–647. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang S, Liu H, Wang Q, Cheng Z, Sun S,
Zhang Y, Sun X, Wang Z and Ren L: Neutrophil-to-lymphocyte ratio
and platelet-to-lymphocyte ratio are effective predictors of
prognosis in patients with acute mesenteric arterial embolism and
thrombosis. Ann Vasc Surg. 49:115–122. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Luo Q, Li X, Zhao Z, Zhao Q, Liu Z and
Yang W: Nomogram for hospital-acquired venous thromboembolism among
patients with cardiovascular diseases. Thromb J.
22(15)2024.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Selvaggio S, Brugaletta G, Abate A, Musso
C, Romano M, Di Raimondo D, Pirera E, Dattilo G and Signorelli SS:
Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio and
monocyte-to-HDL cholesterol ratio as helpful biomarkers for
patients hospitalized for deep vein thrombosis. Int J Mol Med.
51(52)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Artoni A, Abbattista M, Bucciarelli P,
Gianniello F, Scalambrino E, Pappalardo E, Peyvandi F and
Martinelli I: Platelet to lymphocyte ratio and neutrophil to
lymphocyte ratio as risk factors for venous thrombosis. Clin Appl
Thromb Hemost. 24:808–814. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Robalo Nunes A and Tátá M: The impact of
anaemia and iron deficiency in chronic obstructive pulmonary
disease: A clinical overview. Rev Port Pneumol (2006). 23:146–155.
2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lederer AK, Maul-Pavicic A, Hannibal L,
Hettich M, Steinborn C, Gründemann C, Zimmermann-Klemd AM, Müller
A, Sehnert B, Salzer U, et al: Vegan diet reduces neutrophils,
monocytes and platelets related to branched-chain amino acids-A
randomized, controlled trial. Clin Nutr. 39:3241–3250.
2020.PubMed/NCBI View Article : Google Scholar
|